BioViva Science is a biotech company, which develops and licenses gene therapies and procedures for cellular degeneration and genetic disorders. It offers therapies in the areas of atherosclerosis, adeno-associated virus, adrenoleukodystrophy, Alzheimer’s, diabetes, weight management, ALS, Parkinson's, rheumatoid arthritis, and wet macular degeneration.